Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Janardan Khandakar"'
Publikováno v:
Cancer. 73:688-691
BACKGROUND Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated. METHODS Ambulatory patients with advanced urothelia